TuHURA Biosciences Inc
HURA
NASDAQ
Biotechnology
$2.47
USD
+0.17 (+7.39%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $147.11M
Volume 317.1K
Revenue
$0
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
$-30.92M
TTM
— YoY
Operating Cash Flow
$-27.30M
TTM
— YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 2.0 | 4.9 | 1.8 | -1.6 | 2.3 |
Other Operating Expenses | 0.4 | 0.0 | 0.0 | 3.7 | 0.0 |
Total Operating Expenses | 7.0 | 9.9 | 6.7 | 8.2 | 7.5 |
Operating Income | -7.0 | -9.9 | -6.7 | -8.2 | -7.5 |
EBITDA | -6.6 | -9.9 | -6.7 | -4.5 | -7.5 |
Other Income / Expense | 0.3 | 0.3 | -0.4 | 2.0 | 0.0 |
Total Other Income / Expense | 0.4 | 0.4 | -0.4 | 1.4 | -0.0 |
Income Before Income Taxes | -6.7 | -9.5 | -7.1 | -6.8 | -7.5 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -6.7 | -9.5 | -7.1 | -6.8 | -7.5 |
Consolidated Net Income / Loss | -6.7 | -9.5 | -7.1 | -6.8 | -7.5 |
Net Income Attributable to Common Shareholders | -6.7 | -9.5 | -7.1 | -6.8 | -7.5 |
Basic EPS | -$0.15 | -$0.21 | -$0.14 | -$0.13 | -$0.13 |
Diluted EPS | -$0.15 | -$0.21 | -$0.14 | -$0.13 | -$0.13 |
Basic Shares Outstanding | 43.4M | 44.6M | 50.7M | 53.1M | 60.0M |
Diluted Shares Outstanding | 43.4M | 44.6M | 50.7M | 53.1M | 60.0M |